Home>Topics>Companies>Medtronic

Medtronic MDT

  1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Fund Reports
  6. ETF Reports
  7. Headlines
    1. Medtronic peripheral intervention device cost effective as well as clinically superior

      Headlines

      Tue, 16 Sep 2014

      In two studies, Medtronic 's ( MDT +0.3% ) IN.PACT Admiral drug-coated balloon (DCB) peripheral artery intervention device outperformed standard percutaneous

    2. Delcath shareholder recruits supporters

      Headlines

      Thu, 11 Sep 2014

      Linkedto also states that it has become aware that the BOD has had discussions with potential acquirers, including Medtronic , over the past few years about a potential transaction. The market remains unconvinced. Shares were up a fraction

    3. Medtronic : Benefits Of Covidien Acquisition Not Enough To Make It A Buy

      Headlines

      Wed, 10 Sep 2014

      detailed quantitative analysis of Medtronic Inc. (NYSE: MDT ). Below are some highlights ..... analysis: Company Description: Medtronic Inc. is a global medical device ..... P/E Price 4. Graham Number MDT is trading at a premium to all

    4. First patients implanted in recapturable aortic valve clinical trial

      Headlines

      Wed, 10 Sep 2014

      The clinical trial evaluating the safety and efficacy of Medtronic 's ( MDT +0.7% ) CoreValve Evolut R System is underway. The primary efficacy endpoints in the 250-patient prospective study are all

    5. New Morningstar Analyst Report for Insulet Corp

      Stock Reports

      Thu, 4 Sep 2014

      well-financed competitors like Medtronic , Abbott, Roche, and Johnson ..... relationships with medical professionals. Medtronic is developing its own tubeless insulin ..... margins. However, we note that Medtronic has run into delay after delay with

    6. New Morningstar Analyst Report for St Jude Medical Inc

      Stock Reports

      Thu, 4 Sep 2014

      Jude remains a distant second to Medtronic in the implantable cardioverter ..... wake of disappointing results from Medtronic 's controlled trial for renal denervation ..... 2014 time frame. Even though rival Medtronic eked out some pacemaker share gains

    7. Top 10 Buys and Sells by the Ultimate Stock-Pickers

      Headlines

      Wed, 3 Sep 2014

      here . Disclosure: Greggory Warren owns shares in the following securities mentioned above: Citigroup, Covidien, Medtronic , Mondelez International, and Procter & Gamble. It should also be noted that Morningstar's Institutional Equity Research

    8. Medtronic begins large scale CRT trial

      Headlines

      Wed, 27 Aug 2014

      Medtronic ( MDT ) commences a 3,000-patient 200-site post market clinical trial to assess the superiority of cardiac resynchronization therapy

    9. Medtronic buys remaining part of Italian med services firm

      Headlines

      Wed, 27 Aug 2014

      Medtronic (NYSE: MDT ) acquires the 70% of privately-held Italian firm NGC Medical S ..... company at $350M. NGC will serve as the Managed Services arm for Medtronic 's Hospital Solutions business. NGC manages cardiovascular suites

    10. Medtronic buys deep brain stimulation firm

      Headlines

      Tue, 26 Aug 2014

      Medtronic (NYSE: MDT ) acquires privately-held Dutch firm Sapiens Steering Brain Stimulation ..... stimulation of the target while reducing the potential for side effects. Medtronic will integrate Sapiens into its neuromodulation business. 1 comment

    « Prev12345Next »
    Content Partners